|
抗肺炎球菌血清型15B单克隆抗体[克隆2F4]22/278
|
EA
|
22/278
|
2883
|
1-4/12周
|
|
抗肺炎球菌血清型6B单克隆抗体[克隆14-102CC2ID9]22/290
|
EA
|
22/290
|
2883
|
1-4/12周
|
|
抗肺炎球菌血清型4单克隆抗体[克隆14-100JA2IIE72G6]22/286
|
EA
|
22/286
|
2883
|
1-4/12周
|
|
抗肺炎球菌血清型5单克隆抗体[克隆1366KG3IA11]22/288
|
EA
|
22/288
|
2883
|
1-4/12周
|
|
第1批英夫利昔单抗抗药物抗体国际参考盘22/272
|
EA
|
22/272
|
10203
|
1-4/12周
|
|
流感病毒传染性SAN-015[A/Lyon/820/2021][H1N1]22/268
|
EA
|
22/268
|
咨询
|
1-4/12周
|
|
抗肺炎球菌血清型35B单克隆抗体[克隆3F6]22/266
|
EA
|
22/266
|
2883
|
1-4/12周
|
|
流感病毒传染性IVR-215[A/Victoria/2570/2019][H1N1]22/274
|
EA
|
22/274
|
咨询
|
1-4/12周
|
|
抗肺炎球菌血清型2单克隆抗体[克隆1G7]22/276
|
EA
|
22/276
|
2883
|
1-4/12周
|
|
第1批有关SARS-CoV-2相关变体抗体的国际参考盘22/270
|
EA
|
22/270
|
10203
|
1-4/12周
|
|
抗肺炎球菌血清型19F单克隆抗体[克隆8E9-1B12]22/260
|
EA
|
22/260
|
2883
|
1-4/12周
|
|
抗肺炎球菌血清型16F单克隆抗体[克隆20-121HC4IA4IE6]22/258
|
EA
|
22/258
|
2883
|
1-4/12周
|
|
抗肺炎球菌血清型15A/B单克隆抗体[克隆3A4]22/256
|
EA
|
22/256
|
2883
|
1-4/12周
|
|
抗肺炎球菌血清型6C单克隆抗体[克隆1B2]22/254
|
EA
|
22/254
|
2883
|
1-4/12周
|
|
抗肺炎球菌血清型24F单克隆抗体[克隆1A6]22/264
|
EA
|
22/264
|
2883
|
1-4/12周
|
|
抗肺炎球菌血清型23F单克隆抗体[克隆15-113HA6IG2]22/262
|
EA
|
22/262
|
2883
|
1-4/12周
|
|
抗肺炎球菌血清型17F单克隆抗体[克隆17-120DG2IF2]22/246
|
EA
|
22/246
|
2883
|
1-4/12周
|
|
抗肺炎球菌血清型20单克隆抗体[克隆18-121DF9IIG81B6]22/248
|
EA
|
22/248
|
2883
|
1-4/12周
|
|
第2批WHOSARS-CoV-2RNA国际标准22/252
|
EA
|
22/252
|
4988
|
1-4/12周
|
|
抗肺炎球菌血清型11A单克隆抗体[克隆8G12]22/242
|
EA
|
22/242
|
2883
|
1-4/12周
|
